BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34214844)

  • 1. Retinoblastoma tumor suppressor gene 1 enhances 5-Fluorouracil chemosensitivity through SDF-1/CXCR4 axis by regulating autophagy in gastric cancer.
    Tang H; Long Q; Zhuang K; Han K; Zhang X; Guo H; Lu X
    Pathol Res Pract; 2021 Aug; 224():153532. PubMed ID: 34214844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CISD2 enhances the chemosensitivity of gastric cancer through the enhancement of 5-FU-induced apoptosis and the inhibition of autophagy by AKT/mTOR pathway.
    Sun Y; Jiang Y; Huang J; Chen H; Liao Y; Yang Z
    Cancer Med; 2017 Oct; 6(10):2331-2346. PubMed ID: 28857517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer.
    Yu X; Shi W; Zhang Y; Wang X; Sun S; Song Z; Liu M; Zeng Q; Cui S; Qu X
    Sci Rep; 2017 Feb; 7():42226. PubMed ID: 28176874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trim14 promotes autophagy and chemotherapy resistance of gastric cancer cells by regulating AMPK/mTOR pathway.
    Xiao F; Ouyang B; Zou J; Yang Y; Yi L; Yan H
    Drug Dev Res; 2020 Aug; 81(5):544-550. PubMed ID: 32096264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy Facilitates Metadherin-Induced Chemotherapy Resistance Through the AMPK/ATG5 Pathway in Gastric Cancer.
    Pei G; Luo M; Ni X; Wu J; Wang S; Ma Y; Yu J
    Cell Physiol Biochem; 2018; 46(2):847-859. PubMed ID: 29635244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
    Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
    Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardamonin, a natural chalcone, reduces 5-fluorouracil resistance of gastric cancer cells through targeting Wnt/β-catenin signal pathway.
    Hou G; Yuan X; Li Y; Hou G; Liu X
    Invest New Drugs; 2020 Apr; 38(2):329-339. PubMed ID: 31102118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regenerating Family Member 4 (Reg4) Enhances 5-Fluorouracil Resistance of Gastric Cancer Through Activating MAPK/Erk/Bim Signaling Pathway.
    Jin J; Lv H; Wu J; Li D; Chen K; Zhang F; Han J; Feng J; Zhang N; Yu H; Su D; Ying L
    Med Sci Monit; 2017 Jul; 23():3715-3721. PubMed ID: 28759561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA COL1A1-014 is involved in the progression of gastric cancer via regulating CXCL12-CXCR4 axis.
    Dong XZ; Zhao ZR; Hu Y; Lu YP; Liu P; Zhang L
    Gastric Cancer; 2020 Mar; 23(2):260-272. PubMed ID: 31650323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-623 Targets Cyclin D1 to Inhibit Cell Proliferation and Enhance the Chemosensitivity of Cells to 5-Fluorouracil in Gastric Cancer.
    Jiang L; Yang W; Bian W; Yang H; Wu X; Li Y; Feng W; Liu X
    Oncol Res; 2018 Dec; 27(1):19-27. PubMed ID: 29495973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma.
    Zhao BC; Wang ZJ; Mao WZ; Ma HC; Han JG; Zhao B; Xu HM
    World J Gastroenterol; 2011 May; 17(19):2389-96. PubMed ID: 21633638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROS-Induced CXCR4 Signaling Regulates Mantle Cell Lymphoma (MCL) Cell Survival and Drug Resistance in the Bone Marrow Microenvironment via Autophagy.
    Chen Z; Teo AE; McCarty N
    Clin Cancer Res; 2016 Jan; 22(1):187-99. PubMed ID: 26350264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGA1B/2 transcriptionally activated-POU1F1 facilitates gastric carcinoma metastasis via CXCL12/CXCR4 axis-mediated macrophage polarization.
    Tang C; Lei X; Xiong L; Hu Z; Tang B
    Cell Death Dis; 2021 Apr; 12(5):422. PubMed ID: 33927188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The disparate twins: a comparative study of CXCR4 and CXCR7 in SDF-1α-induced gene expression, invasion and chemosensitivity of colon cancer.
    Heckmann D; Maier P; Laufs S; Li L; Sleeman JP; Trunk MJ; Leupold JH; Wenz F; Zeller WJ; Fruehauf S; Allgayer H
    Clin Cancer Res; 2014 Feb; 20(3):604-16. PubMed ID: 24255072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role and mechanism research on reversal of 5-fluorouracil resistance by epigallocatechin gallate in gastric cancer drug-resistance cells lines SGC-7901/5-FU].
    Tang H; Zhang X; Cui S; Wang J; Ruan Q; Huang Y; Yang D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1170-1175. PubMed ID: 27781257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPARC enhances 5-FU chemosensitivity in gastric cancer by modulating epithelial-mesenchymal transition and apoptosis.
    Ma J; Ma Y; Chen S; Guo S; Hu J; Yue T; Zhang J; Zhu J; Wang P; Chen G; Liu Y
    Biochem Biophys Res Commun; 2021 Jun; 558():134-140. PubMed ID: 33910127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentivirus-mediated shRNA targeting of cyclin D1 enhances the chemosensitivity of human gastric cancer to 5-fluorouracil.
    Seo JH; Jeong ES; Lee KS; Heo SH; Jeong DG; Choi YK
    Int J Oncol; 2013 Dec; 43(6):2007-14. PubMed ID: 24100731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of the anticancer effect of doxorubicinin drug-resistant gastric cancer cells by tanshinone IIA.
    Xu Z; Chen L; Xiao Z; Zhu Y; Jiang H; Jin Y; Gu C; Wu Y; Wang L; Zhang W; Zuo J; Zhou D; Luan J; Shen J
    Phytomedicine; 2018 Dec; 51():58-67. PubMed ID: 30466628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extract of
    Cui XL; Li KJ; Ren HX; Zhang YJ; Liu XD; Bu BG; Wang L
    World J Gastroenterol; 2019 Apr; 25(15):1854-1864. PubMed ID: 31057299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4.
    Azar MRMH; Aghazadeh H; Mohammed HN; Sara MRS; Hosseini A; Shomali N; Tamjidifar R; Tarzi S; Mansouri M; Sarand SP; Marofi F; Akbari M; Xu H; Shotorbani SS
    Int Immunopharmacol; 2021 Mar; 92():107355. PubMed ID: 33429333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.